Clarametyx is a startup based in the United States.
Clarametyx Biosciences is a clinical stage biopharmaceutical company developing immune-enabling biologic therapies that target bacterial biofilms to treat chronic respiratory diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.